Skip to main content

Deeply committed to aortic treatment

In the constant pursuit to improve outcomes, we join in service with physicians to engineer powerful products and form empowering partnerships. This is our deep commitment to innovation that the aortic medical community has relied on and can continue to count on now and in the future.

Deep commitment Continual pursuit Beyond products

Solving unmet needs through innovation

The only AAA device that is infrarenal by design, intended to help mitigate the risks associated with suprarenal fixation devices.

Download flyer

“Stent grafts with active fixation below the renal arteries as well as oversizing by less than 10% seem to have the least effect on aortic neck degeneration over time…”

Addressing unique abdominal aortic needs with controlled conformability


Download brochure

Medical device

Introduction of angulation control for EVAR and TEVAR

Impact to TEVAR approach

Evolving TEVAR:
Vascular Surgeon shares his experience with TEVAR device

The first and only FDA approved iliac branch solution, fully designed to preserve blood flow to iliac arteries


Why and when to preserve

The continual pursuit to improve outcomes

We have multiple clinical and investigational trials in process, supporting a robust aortic pipeline.


Thoracic branch


Our commitment goes beyond products to build partnerships that empower

Together - Video Thumbnail

Our commitment to lifelong innovation 

View video

  1. Kay B.  Active stent-graft fixation below the renal arteries may have the least effect on aortic neck degeneration, study finds.  Vascular Specialist -Society for Vascular Surgery (SVS) website.  Posted November 17, 2020.  Accessed December 2, 2020.

* Three year follow-up of U.S. IDE Clinical Trial for all patients from primary enrollment (n = 63)